The myHER2 app is an interactive and personalised support tool designed for women or men with HER2-positive breast cancer who have been prescribed Herceptin (trastuzumab) or Perjeta (pertuzumab) + Herceptin or Kadcyla (trastuzumab emtansine). The Home Screen displays the key modules of the app. The app includes features such as: • Treatment Plan - to assist in managing infusion appointments • Symptom Tracker - to log symptoms and track well-being • Support Resources - information about HER2-positive breast cancer, treatment and direct access to support networks • Personal Profile - to store the healthcare and emergency contact details. less
|
